Article, 2024

Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study

Journal of the European Academy of Dermatology and Venereology, ISSN 1468-3083, 0926-9959, 10.1111/jdv.20165

Contributors

Rønnstad, Amalie Thorsti Møller 0000-0001-9949-9726 (Corresponding author) [1] Nielsen, Mia-Louise 0000-0002-1562-8568 [1] Schlapbach, Christoph 0000-0003-0258-1243 [2] [3] Guttman-Yassky, E G Y 0000-0002-9363-324X [4] Silverberg, Jonathan Ian 0000-0003-3686-7805 [5] Thomsen, Simon Francis [1] Thyssen, Jacob Pontoppidan 0000-0003-3770-1743 [1] Egeberg, Alexander 0000-0001-8257-1816 [1]

Affiliations

  1. [1] Bispebjerg and Frederiksberg Hospital
    2. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  2. [2] University Hospital of Bern
    3. [NORA names: Switzerland; Europe, Non-EU; OECD];
  3. [3] University of Bern
    4. [NORA names: Switzerland; Europe, Non-EU; OECD];
  4. [4] Icahn School of Medicine at Mount Sinai
    5. [NORA names: United States; America, North; OECD];
  5. [5] George Washington University
    6. [NORA names: United States; America, North; OECD]

Keywords

Danish nationwide cohort study, alitretinoin treatment, chronic hand eczema, cohort study, drug, drug survival, eczema, hand eczema, nationwide cohort study, study, treatment

Funders

  • AbbVie (United States)
  • Agricultural Research Service
  • Boehringer Ingelheim (United States)
  • Kirin (Japan)
  • Regeneron (United States)
  • Amgen (United States)
  • AstraZeneca (United States)
  • GlaxoSmithKline (United Kingdom)
  • Novartis (United States)
  • Johnson & Johnson (United States)
  • Bristol-Myers Squibb (United States)
  • National Psoriasis Foundation
  • Teva Pharmaceuticals (United States)
  • Otsuka (United States)
  • Sanofi (United States)
  • Pfizer (United States)
  • Google (United States)
  • Sun Pharma (India)

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+